Maurer, Marcus; Altrichter, Sabine; Bieber, Thomas et al.
Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidaseJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. Bd. 128. H. 1. 2011 S. 202-U326
Schmidt, T; Belz, M; Luckey, U et al.
Epicutaneously- and orally-induced tolerance to allergens protects from aTh1-mediated colitisEXPERIMENTAL DERMATOLOGY. Bd. 20. H. 2. 2011 S. 163-163
Rietz, S; Mohler, T; Brauninger, W et al.
Erythematosus plaques and nodules in a 50-year old patient with rheumatoid arthritisJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 9. H. 1. 2011 S. 67-69
Bellinghausen, I; Weigmann, B; Wiebe, C et al.
Establishment of an IgE- and mast cell- (histamine and platelet-activating factor) dependent humanized mouse model for allergic gut inflammationEXPERIMENTAL DERMATOLOGY. Bd. 20. H. 2. 2011 S. 163-163
Steinacker, J; Tenzer, S; Bank, E et al.
Exploring molecular mechanisms of apoptosis in the protozoan parasite Leishmania majorINTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY. Bd. 301. 2011 S. 15-15
Liss, Y; Haustein, UF; Bork, K et al.
Generalized bullous fixed Drug eruption (GBFDE) versus Stevens-Johnson syndrome (SJS) and Toxic epidermal Necrolysis (TEN): Differences in Clinic, Etiology and PrognosisJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 9. 2011 S. 150-150
Lausch, E; Janecke, A; Bros, M et al.
Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunityNATURE GENETICS. Bd. 43. H. 2. 2011 S. 132-U79
Heydenreich, B; Bellinghausen, I; Henmar, H et al.
Glutaraldehyde modified allergoids induce diminished T cell responsesEXPERIMENTAL DERMATOLOGY. Bd. 20. H. 2. 2011 S. 163-163
Weller, Karsten; Ziege, Claudia; Staubach, Petra et al.
H-1-Antihistamine Up-Dosing in Chronic Spontaneous Urticaria: Patients' Perspective of Effectiveness and Side Effects - A Retrospective Survey StudyPLOS ONE. Bd. 6. H. 9. 2011
Bork, K; Hardt, J
Hereditary Angioedema: Long-Term Treatment with One or More Injections of C1 Inhibitor Concentrate per WeekINTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY. Bd. 154. H. 1. 2011 S. 81-88